ER-negative PR-negative HER2/neu-negative breast cancer
Term · Oncology and biomedicine · MLC-T-ONC-002957
A type of breast cancer in which the tumor cells do not have estrogen receptors, progesterone receptors, or large amounts of HER2/neu protein on their surface. Knowing whether breast cancer is triple negative is important in planning treatment. Also called TNBC and triple-negative breast cancer.
ER-negative PR-negative HER2/neu-negative breast cancer is defined by a lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu). Also called TNBC and triple-negative breast cancer.
| Identifier | MLC-T-ONC-002957 |
|---|---|
| Field | Oncology and biomedicine |
| Synonyms | TNBC; triple-negative breast cancer |
| References | NCI Dictionary of Cancer Terms; NCI Dictionary of Genetics Terms |
Record as JSON
{
"id": "MLC-T-ONC-002957",
"term": "ER-negative PR-negative HER2/neu-negative breast cancer",
"field": "Oncology and biomedicine",
"definitions": [
"A type of breast cancer in which the tumor cells do not have estrogen receptors, progesterone receptors, or large amounts of HER2/neu protein on their surface. Knowing whether breast cancer is triple negative is important in planning treatment. Also called TNBC and triple-negative breast cancer.",
"ER-negative PR-negative HER2/neu-negative breast cancer is defined by a lack of expression of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2/neu). Also called TNBC and triple-negative breast cancer."
],
"synonyms": [
"TNBC",
"triple-negative breast cancer"
],
"references": [
"NCI Dictionary of Cancer Terms",
"NCI Dictionary of Genetics Terms"
],
"url": "https://mlchart.com/terminology/oncology/er-negative-pr-negative-her2-neu-negative-breast-cancer/"
}
Record 6,870 of 17,721 in Oncology and biomedicine terminology (MLC-0111). Request the full dataset.